Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-09

Clinical Trial Update: Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of Tenofovir Disoproxil in adults with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir disoproxil (Tenofovir disoproxil)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED